| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.24 | 5e-07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.25 | 4e-05 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |